Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel thiopurine S-methyltransferase (TPMT) variant identified in Malay individuals. | Clin Chem Lab Med | 2024 | 38661453 | PubTator, text mining | PubMed |
| Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers. | World J Gastroenterol | 2024 | 38617736 | PubTator, text mining | PubMed |
| Drug reactive metabolite-induced hepatotoxicity: a comprehensive review. | Toxicol Mech Methods | 2024 | 38504503 | PubTator, text mining | PubMed |
| TCHH as a Novel Prognostic Biomarker for Patients with Gastric Cancer by Bioinformatics Analysis. | Clin Exp Gastroenterol | 2024 | 38434179 | PubTator, text mining | PubMed |
| NUDT15 and TPMT polymorphisms in three distinct native populations of the Brazilian Amazon. | Front Pharmacol | 2024 | 38379902 | PubTator, text mining | PubMed |
| Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis. | Pharmacogenet Genomics | 2024 | 38359167 | PubTator, text mining | PubMed |
| Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study. | Haematologica | 2024 | 38356449 | PubTator, text mining | PubMed |
| Biomarkers That Predict Crohn's Disease Outcomes. | J Can Assoc Gastroenterol | 2024 | 38314176 | PubTator, text mining | PubMed |
| White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort Study. | Inflamm Intest Dis | 2024 | 38298887 | PubTator, text mining | PubMed |
| Exploring the role of oxidative stress and the effect of N-acetylcysteine in thiopurine-induced liver injury in inflammatory bowel disease: A randomized crossover pilot study. | Basic Clin Pharmacol Toxicol | 2024 | 38284479 | PubTator, text mining | PubMed |
| New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases. | Ther Adv Gastroenterol | 2024 | 38282956 | PubTator, text mining | PubMed |
| The Case for Pre-Emptive Pharmacogenetic Screening in South Africa. | J Pers Med | 2024 | 38276236 | PubTator, text mining | PubMed |
| Heart Transplantation. | J Clin Med | 2024 | 38256691 | PubTator, text mining | PubMed |
| Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps. | J Clin Med | 2024 | 38256585 | PubTator, text mining | PubMed |
| Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations. | J Natl Cancer Inst | 2024 | 38230823 | PubTator, text mining | PubMed |
| Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity. | Pharmacogenomics J | 2024 | 38216550 | PubTator, text mining | PubMed |
| Chemotherapeutic metabolism presenting as a recalcitrant case of hand-foot syndrome and mucositis. | J Oncol Pharm Pract | 2024 | 38204187 | PubTator, text mining | PubMed |
| Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. | RMD Open | 2024 | 38199851 | PubTator, text mining | PubMed |
| Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease. | Lupus Sci Med | 2024 | 38176699 | PubTator, text mining | PubMed |
| ProSTAGE: Predicting Effects of Mutations on Protein Stability by Using Protein Embeddings and Graph Convolutional Networks. | J Chem Inf Model | 2024 | 38166383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=10